SCHEMBL18426052

SCHEMBL18426052

CONC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1NCc1cccs1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CISD1 Q9NZ45 10/20 0.76
▸ PDE4D Q08499 1/20 0.56
▸ PDE3A Q14432 1/20 0.56
▸ CA1 P00915 8/20 0.56
▸ CA2 P00918 8/20 0.56
▸ CA7 P43166 8/20 0.56
▸ CA5B Q9Y2D0 8/20 0.56
▸ CA12 O43570 7/20 0.56
▸ CA6 P23280 7/20 0.56
▸ CA9 Q16790 7/20 0.56
▸ CA14 Q9ULX7 7/20 0.56
▸ CA5A P35218 7/20 0.56
▸ CA3 P07451 6/20 0.56
▸ CA13 Q8N1Q1 6/20 0.56
▸ CA4 P22748 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ HSD11B1 P28845 1/20 0.50
▸ SLC10A1 Q14973 1/20 0.50
▸ GPR35 Q9HC97 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714459 0.86 CISD1 (1.00) CISD1PDE4DPDE3ACA1CA2
SCHEMBL2873972 0.75 CISD1 (0.69) CISD1PDE4DPDE3ACA1CA2
SCHEMBL11788810 0.74 CISD1 (0.74) CISD1PDE4DPDE3ACA1CA2
SCHEMBL18426049 0.74 CISD1 (0.44) CISD1CA1CA2CA7CA5B
SCHEMBL11789259 0.74 CISD1 (0.73) CISD1PDE4DPDE3ACA1CA2
Azosemide SCHEMBL1649512 0.72 PDE4D (1.00) CISD1PDE4DPDE3ACA1CA2
SCHEMBL18993718 0.72 PDE4D (0.59) CISD1PDE4DPDE3ACA1CA2
SCHEMBL18425099 0.72 CISD1 (0.78) CISD1CA1CA2CA7CA5B
SCHEMBL11875494 0.72 CISD1 (0.73) CISD1PDE4DPDE3ACA1CA2
SCHEMBL18425147 0.71 CA1 (1.00) CISD1CA1CA2CA7CA5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180222856-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2018-08-09 — — US claimed
EP-3328833-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE Vilnius University (LT) 2018-06-06 — — EP claimed
WO-2017017505-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2017-02-02 — — WO claimed
EP-3328833-B1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE UNIV VILNIUS (LT) 2025-08-06 — — EP disclosed
US-11312682-B2 Selective inhibitors of carbonic anhydrase VILNIUS UNIVERSITY (LT) 2022-04-26 — — US disclosed
US-20180222856-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2018-08-09 — — US disclosed
EP-3328833-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE Vilnius University (LT) 2018-06-06 — — EP disclosed
WO-2017017505-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE VILNIUS UNIVERSITY (LT) 2017-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312682-B2 Selective inhibitors of carbonic anhydrase CA2, CA9, CA7 CISD1 1710/4885PDE4D 2235/4885PDE3A 785/4885
US-20180222856-A1 SELECTIVE INHIBITORS OF CARBONIC ANHYDRASE CA9, CA2, CA7 CISD1 1577/4885PDE4D 2139/4885PDE3A 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback